Common Psychosocial Factors Underlying Breast Cancer Screening And Breast Cancer Treatment Adherence: A Conceptual Review And Synthesis
Authors:
- 1 January 2007
- journal article
- review article
- Published by SAGE Publications in Journal of Women's Health
- Vol. 16 (1) , 11-23
Abstract
In this paper, we review the literature on psychosocial influences on breast cancer screening and treatment adherence with an eye to identifying common cognitive, emotional, and social network factors that may lead to poor screening adherence and suboptimal treatment in the case of diagnosed breast cancer. Nonadherence to breast cancer screening and treatment guidelines can significantly and negatively impact the prospects for prevention and control of breast cancer. Psychosocial factors are an especially important focus for research, inasmuch as belief structures and psychosocial characteristics (such as patterns of emotion regulation and the quality of social relations) are modifiable and are, thus, eminently suitable to intervention.Keywords
This publication has 135 references indexed in Scilit:
- Incidence and Predictors of Low Dose-Intensity in Adjuvant Breast Cancer Chemotherapy: A Nationwide Study of Community PracticesJournal of Clinical Oncology, 2003
- Cancer FatalismCancer Nursing, 2003
- Negative Affect and Health: The Importance of Being EarnestCognition and Emotion, 1999
- Attitudes About Breast Cancer and Mammography: Racial, Income, and Educational DifferencesWomen & Health, 1997
- Evidence for the Distinctness of Embarrassment, Shame, and Guilt: A Study of Recalled Antecedents and Facial Expressions of EmotionCognition and Emotion, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Illness cognition: Using common sense to understand treatment adherence and affect cognition interactionsCognitive Therapy and Research, 1992
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Social transgressions, social perspectives, and social emotionalityMotivation and Emotion, 1981